Home » Topics » BioWorld Science

BioWorld Science
RSS

Microbiotica and Genentech enter strategic collaboration for IBD

June 7, 2018

Virpax signs license agreement to use LipoCure's liposome drug delivery technology

June 7, 2018

First patient enrolled in phase IIa study of THX-110

June 6, 2018

Merck & Co. describes DGAT-2 inhibitors

June 6, 2018

Cognition Therapeutics doses first patient in SNAP study of Elayta

June 6, 2018

Amgen identifies new apelin receptor agonists

June 6, 2018

EZH2 inhibitors patented by Yangtze River Pharmaceutical, Shanghai Haiyan Pharmaceutical Technology

June 6, 2018

Nimbus Therapeutics announces new financing

June 6, 2018

Axovant licenses gene therapy for Parkinson's disease from Oxford BioMedica

June 6, 2018

Independent DMC completes last intermediate review of SCiStar study of AST-OPC1

June 6, 2018

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...